about
Sham surgery and inter-individual heterogeneity are major determinants of monocyte subset kinetics in a mouse model of myocardial infarctionStructural Insight into Unique Cardiac Myosin-binding Protein-C Motif: A PARTIALLY FOLDED DOMAINRecent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsA critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac functionProtein kinase D increases maximal Ca2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cyclingGSK3β phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communicationAnalysis of cardiac myosin binding protein-C phosphorylation in human heart muscleNovel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylationMyocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardiumTargeted genome-wide enrichment of functional regionsCardiac myosin-binding protein-C phosphorylation and cardiac functionPhosphorylation of cMyBP-C affects contractile mechanisms in a site-specific mannerTransmural heterogeneity of cellular level power output is reduced in human heart failure.Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary SyndromeSurviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.Cardiac myosin binding protein C phosphorylation affects cross-bridge cycle's elementary steps in a site-specific manner.Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathyEffects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failureCardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and functionEnhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascadeA hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunctionCeramide-mediated depression in cardiomyocyte contractility through PKC activation and modulation of myofilament protein phosphorylationCardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation.Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κBHaploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate.Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase AS-glutathiolation impairs phosphoregulation and function of cardiac myosin-binding protein C in human heart failure.Agonist activated PKCβII translocation and modulation of cardiac myocyte contractile function.In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failureAlterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C.Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain backgroundInducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.Interactions between the regulatory subunit of type I protein kinase A and p90 ribosomal S6 kinase1 regulate cardiomyocyte apoptosis.Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.Finding the missing link: disulfide-containing proteins via a high-throughput proteomics approach.
P50
Q27325806-70980A93-3D9B-42F3-9CCC-99D10C360BC8Q27676683-76E734DC-98F8-4579-9A4F-84F57B5C3050Q28075331-6F58780D-A778-4810-BAB8-C024486A6A1BQ28238191-2BCAB05C-64E7-4A85-9751-06885EDEEB18Q28267520-91227FC5-754B-4B58-B575-9EEB2975F78EQ28268017-CBC6EF98-34A4-474D-8FAA-131A56AC4090Q28282353-4DF78284-59EC-4EFF-B26D-C817442200FCQ28293588-23C6A42F-81CB-41BB-9A4E-46332B8F7F39Q28300397-1D095666-9BD3-4568-81A4-9257AAEEE8E9Q28307520-5FD4D72E-5363-48CC-9064-8072D4C3BB70Q28474475-588622B8-D18E-410A-93B1-574B8934ED09Q28584863-11608A58-04E0-45F8-9762-6D65B6279069Q33634074-A48003FB-9735-4720-8B61-75A462CEDA36Q33680561-43661AB3-DBEE-4541-8901-24D6D4FC190EQ33768996-3E20FC1A-3BD0-47A1-B5C8-5F42E41CC030Q34172185-A968107A-72DC-4BA5-8540-294AD0F9F6CAQ34566207-B51BBA80-70D5-483D-B024-7FD3AA48B78FQ34626001-54CA9588-CD27-4B95-8DD6-87E6FD71DA21Q34627826-33D686E1-564E-4F0A-85AF-FF57873992FEQ34920804-9B98373B-BE17-4CD9-A95E-21246CE2E6CBQ34994899-F40039FD-2E23-470F-817F-50D7AB7455EAQ35126714-96935FA2-0218-483C-AA25-84E9F91A0534Q35634087-2FD9DF38-6E06-4DF0-AC7F-24A6CD3F4552Q35634229-2F86E1EA-18D8-4280-99B4-110C5F702CDBQ36174383-8B4E1907-554C-4257-9A94-B03225024350Q36174897-0DA15856-6879-4DA4-948C-4118DF43B511Q36272676-827E2F1B-B25D-40EB-8ED8-67405CAC5276Q36296869-D358A21A-A788-419B-826D-0D859209AD17Q36444026-F297298F-2929-46E2-9AB9-72B87BA79572Q36599563-C9FDD66C-0A3B-4D15-8B56-315913DADA0DQ36812041-E9F18601-52B8-46F5-9440-EF8C8DE8AF1CQ36920937-1A97F494-5704-4AF7-90B2-D3972831DE7FQ36968582-6C45857E-F2C9-431A-85B7-CB7EFFCA03FEQ37090787-15AA9DFF-0348-4244-9CCA-869725FC7F8FQ37130118-25A54155-A7AE-4F54-BAD3-33D0B14BDB02Q37364808-089E09C2-4E1E-45EF-A903-69E877F4E267Q37372200-850FD4DF-BFFE-4667-9813-A84D4636E949Q37553501-AA493229-291E-4332-A2FA-9221E3B7CA6FQ37576160-C329F94F-AF2E-4E20-A2AE-01A30CBA4C77Q37582155-BC4110B2-EF96-483D-B74B-C7CDF309DAB2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sakthivel Sadayappan
@ast
Sakthivel Sadayappan
@en
Sakthivel Sadayappan
@es
Sakthivel Sadayappan
@nl
type
label
Sakthivel Sadayappan
@ast
Sakthivel Sadayappan
@en
Sakthivel Sadayappan
@es
Sakthivel Sadayappan
@nl
prefLabel
Sakthivel Sadayappan
@ast
Sakthivel Sadayappan
@en
Sakthivel Sadayappan
@es
Sakthivel Sadayappan
@nl
P106
P31
P496
0000-0003-2006-7678